Group 1 - Cadiz (CDZI) focuses on acquiring and developing water-related land and agricultural assets, with a 40% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - ArriVent BioPharma, Inc. (AVBP) is a clinical-stage biopharmaceutical company targeting unmet medical needs in cancer treatment, experiencing a 7.3% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Acco Brands (ACCO) is a leading company in branded office products, with a 5.1% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3]